Research Progress on Mongolian Medicine Improving Tumor Microenvironment
2Department of Oncology, Peking University Cancer Hospital (Inner Mongolia Campus)/Afliated Cancer Hospital of Inner Mongolia Medical University, Hohhot 010020, China
3Department of Traditional Chinese Medicine, Peking University Cancer Hospital (Inner Mongolia Campus)/Afliated Cancer Hospital of Inner Mongolia Medical University, Hohhot 010020, China
4Department of Traditional Chinese Medicine, Inner Mongolia Medical University, Huhhot 010010, China
5The Laboratory for Tumor Molecular Diagnosis, Peking University Cancer Hospital (Inner Mongolia Campus)/Afliated Cancer Hospital of Inner Mongolia Medical University, Hohhot 010020, China
Abstract
1.Introduction
Cancer encompasses a diverse group of
diseases characterized by abnormal cell growth that can invade nearby tissues
and metastasize distant organs [1]. According to the World Health Organization
(WHO), cancer is one of the leading causes of morbidity and mortality globally,
with approximately 10 million deaths attributed to cancer each year [2]. The
burden of cancer varies significantly across different regions and populations
[3], influenced by factors such as genetics, lifestyle choices, environmental
exposures, and access to healthcare. In early detection and treatment have
improved survival rates for certain cancers. However, challenges persist,
particularly in treating aggressive and metastatic forms of the disease. The
emergence of resistance to chemotherapy and targeted therapies further
complicates treatment outcomes, underscoring the urgent need for innovative
therapeutic strategies.
Central to cancer biology is the concept
of the tumor microenvironment (TEM), a complex network of cells, blood vessels,
signaling molecules, and extracellular matrix components that surround and
support tumor cells [4]. The TME is dynamic and heterogeneous, influencing
tumor behavior in profound ways [4]. It is characterized by hypoxia (low oxygen
levels), acidity, immune cell infiltration, and chronic inflammation, all of
which contribute to tumor growth, invasion, and metastasis [5] [6]. Key
components of the TME include cancer-associated fibroblasts (CAFs) [7], immune
cells (such as tumor-associated macrophages, T cells, and myeloid-derived
suppressor cells), endothelial cells, and various signaling molecules [8]
(cytokines, growth factors, and extracellular matrix proteins). Crosstalk
between tumor cells and these components can promote cancer cell survival,
induce angiogenesis (formation of new blood vessels), and create an
immunosuppressive environment that shields tumors from immune surveillance.
Understanding the mechanisms that govern
TME dynamics is crucial for developing targeted therapies that disrupt
tumor-promoting interactions while preserving normal tissue function [9].
Recent research has identified several pathways and molecular mechanisms
involved in TME modulation [10], offering potential targets for therapeutic
intervention. For instance, the hypoxic conditions within the TME activate
hypoxia-inducible factors (HIFs), transcription factors that regulate genes
involved in angiogenesis, metabolism, and resistance to therapy. Additionally,
inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and
interleukin-6 (IL-6) contribute to chronic inflammation, which can promote
tumor growth and metastasis. Furthermore, the role of immune cells in shaping the TME has garnered significant attention [11].
Tumor-associated macrophages (TAMs) exhibit diverse phenotypes ranging from
pro-inflammatory (M1-like) to immunosuppressive (M2-like) [12], influencing
both anti-tumor immune responses and tissue remodeling processes. Strategies
aimed at reprogramming TAMs towards an anti-tumor phenotype represent a
promising avenue for therapeutic development [13][14].
Amidst the complexity of cancer
biology, traditional medicine systems like Mongolian medicine offer unique
insights and therapeutic approaches that complement conventional treatments.
Mongolian medicine, deeply rooted in nomadic culture and the natural environment
of the Mongolian steppes, encompasses a rich tradition of herbal remedies,
dietary practices, and therapeutic modalities aimed at restoring balance and
harmony within the body [15]. Mongolian medicine has integrated knowledge from
diverse cultural traditions, including Chinese, Tibetan, and indigenous
Mongolian practices [16]. Herbal medicines derived from plants endemic to the
region are often central to treatment regimens, with formulations tailored to
address specific health conditions, including cancer. Recent research has
increasingly explored the potential of Mongolian medicinal practices in
modulating the TME and improving cancer outcomes [17]. Herbal remedies, in particular, have garnered attention for their bioactive
compounds that exhibit anti-inflammatory, antioxidant, and immunomodulatory
properties. These properties are critical for disrupting tumor-promoting
pathways within the TME while enhancing anti-tumor immune responses. Studies
have highlighted the anti-angiogenic effects of certain Mongolian medicinal
plants [18], which inhibit the formation of new blood vessels crucial for tumor
growth and metastasis. Moreover, bioactive compounds found in these herbs have
been shown to inhibit the expression of pro-inflammatory cytokines and signaling
pathways associated with tumor progression [19]. In addition to herbal
therapies, other aspects of Mongolian medicine such as dietary interventions
and lifestyle practices play a pivotal role in supporting overall health and
immune function [20]. Dietary components rich in antioxidants and
phytochemicals can mitigate oxidative stress and inflammation within the TME,
thereby enhancing the efficacy of conventional therapies.
2.Principles of Mongolian Traditional Medicine
Mongolian
medicine views health as a balance between the individual (body, mind, and
spirit) and their environment [21]. It emphasizes the dynamic interaction
between internal factors (ayu, or vital life force) and external influences
(climate, diet, lifestyle) [22]. While treatment focuses not only on curing
illness but also on preventing disease by maintaining harmony within the body
and its surroundings [23]. Similar to other East Asian
medical traditions, Mongolian medicine employs a Five Elements theory (Earth,
Water, Fire, Wood, Metal). Each element corresponds to specific organs,
seasons, emotions, and qualities. Practitioners use the Five Elements theory to
diagnose imbalances in the body and prescribe treatments that restore harmony
[24]. For example, an excess of "Fire" element might manifest as
fever or inflammation, requiring treatments to cool and balance the body. Similar to Chinese medicine, pulse diagnosis is crucial in
Mongolian medicine. Practitioners assess the pulse at different points to
detect subtle changes that indicate health imbalances. Basis on examination of
the tongue's color, coating, and shape provides further insights into a person's
health condition. Mongolian medicine mainly uses herbal medicine for treatment.
Medicinal plants and herbs form the backbone of Mongolian medicine. Specific
herbs are selected based on their properties (cooling, warming, tonifying) and
their ability to restore balance. Key components or herbs commonly used in
Mongolian medicine include "Shatar" (Allium polyrhizum),
known for its antibacterial properties and use in treating digestive disorders;
"Tsagaan ezen" (Rhodiola quadrifida) [25], valued for its adaptogenic effects in
reducing stress and enhancing resilience; "Nogoon
tsagaan tsetseg"
(Astragalus membranaceus) [26], recognized for its
immune-boosting properties and support for respiratory health; "Zogan tsegi" (Artemisia spp.), used in moxibustion for its
warming and purifying effects; and "Mongol noyon" (Cynomorium songaricum) [27],
prized for its aphrodisiac and rejuvenating properties. These herbs are
selected based on their therapeutic qualities and are often incorporated into
formulations tailored to treat specific health conditions, reflecting the
holistic approach of Mongolian traditional medicine in promoting overall
well-being and resilience. Mongolian medicine also involves inserting fine
needles into specific points on the body to stimulate energy flow (Qi) [28].
Moxibustion uses burning mugwort (moxa) to warm these
points, promoting healing and balance. Food is considered medicinal in
Mongolian tradition. Recommendations are tailored to an individual's
constitution and health condition to support healing and prevent illness.
3.Mechanisms of Mongolian medicine for tumor microenvironment
Mongolian
traditional medicine represents a holistic healthcare system that integrates
ancient wisdom with modern scientific insights to effectively interact with the
tumor microenvironment (TME) [29]. This approach is characterized by a diverse
array of herbal therapies, diagnostic techniques, and holistic treatment
modalities that aim toaddress
cancer at its core while promoting overall well-being [30].
Central to the therapeutic
efficacy of Mongolian medicine are its herbal components, each selected for
their specific medicinal properties and therapeutic effects within the TME.
Herbs such as "Shatar" (Allium polyrhizum)
and "Tsagaan ezen" (Rhodiola quadrifida) are renowned for their potent antioxidant and
anti-inflammatory properties. These herbs play critical roles in reducing
oxidative stress and chronic inflammation within the TME, creating an
environment that is less conducive to tumor growth and metastasis. By
scavenging free radicals and modulating inflammatory pathways, they help to
maintain cellular homeostasis and inhibit the proliferation of cancerous cells.
In addition to their antioxidant and anti-inflammatory effects, such herbs in
Mongolian medicine as "Mongol noyon" (Cynomorium
songaricum) and "Nogoon
tsagaan tsetseg"
(Astragalus membranaceus), exhibit significant
immunomodulatory properties. These herbs enhance the body's immune responses
against cancer cells by activating cytotoxic T cells, natural killer (NK)
cells, and dendritic cells within the TME. By bolstering immune surveillance
and promoting cytotoxicity against tumor cells, these herbs contribute to the
body's natural defense mechanisms against cancer. Complementary therapies in
Mongolian medicine further support these effects. Moxibustion, a technique
utilizing "Zogan tsegi" (Artemisia spp.),
is used to enhance local circulation and lymphatic drainage. Improved
circulation facilitates the delivery of immune cells and therapeutic agents to
the site of the tumor, while enhanced lymphatic drainage aids in the removal of
metabolic wastes and toxins from the TME. These therapies not only support the
efficacy of herbal treatments but also contribute to overall immune function
and systemic health (Table 1).
Diagnostic methods play a crucial role
in Mongolian medicine, providing insights into the underlying imbalances
contributing to cancer progression. Pulse diagnosis, for instance, involves the
assessment of pulse qualities at various points on the radial artery [31].
Practitioners interpret pulse characteristics to identify systemic imbalances
such as stagnation, deficiency, or excess, which may influence cancer
development and progression. Tongue examination is another diagnostic tool used
to assess the body's internal state, with changes in tongue appearance
indicating specific health conditions and guiding herbal prescriptions [32].
Personalized treatment strategies in
Mongolian medicine are tailored based on diagnostic findings and individual
patient needs. By addressing underlying imbalances identified through
diagnostic methods, practitioners aim to restore harmony and balance within the
body [33]. Herbal formulations are customized to target specific aspects of
cancer pathophysiology, whether it be reducing inflammation, enhancing immune
function, or supporting detoxification processes within the TME.
Beyond its specific therapeutic
interventions, Mongolian medicine emphasizes a holistic approach to health and
well-being. This approach acknowledges the interconnectedness of body, mind,
and spirit, emphasizing the importance of lifestyle factors, diet, and
emotional health in cancer prevention and treatment. Recommendations for
dietary modifications, stress management techniques, and supportive therapies
are integral components of holistic cancer care in Mongolian medicine.
Scientific research into the
mechanisms of Mongolian traditional medicine's efficacy in cancer treatment is
advancing, with studies exploring the biochemical pathways, molecular
interactions, and clinical outcomes associated with herbal therapies and integrative
treatments. Emerging evidence supports the role of Mongolian medicine in
enhancing conventional cancer therapies, improving patient outcomes, and
reducing treatment-related side effects.
Table 1.
|
Mongolian Medicine |
Main Components |
Mechanism of Action |
Effects on Cellular Composition |
Effects on Extracellular Matrix |
Effects on Vascular Network |
Immune Regulation |
Metabolic Environment |
Inflammatory Response |
|
Ginseng |
Ginsenosides |
Promotes apoptosis |
Reduces tumor cell proliferation |
Alters ECM structure |
Inhibits angiogenesis |
Activates immune cells |
Lowers metabolic rate |
Inhibits inflammation |
|
Notoginseng |
Notoginsenosides |
Antioxidant effects |
Enhances immune cell activity |
Strengthens ECM support |
Enhances vascular integrity |
Inhibits immune evasion |
Increases oxygen supply |
Alleviates inflammation |
|
Astragalus |
Astragalus polysaccharides |
Inhibits proliferation pathways |
Enhances T cell function |
Reduces ECM stiffness |
Inhibits angiogenesis |
Enhances immune surveillance |
Regulates pH levels |
Reduces chronic inflammation |
|
Ganoderma |
Ganoderma polysaccharides, Ganoderic
acids |
Regulates gene expression |
Enhances NK cell activity |
Promotes ECM degradation |
Increases vascular permeability |
Inhibits immunosuppressive cells |
Reduces acidic environment |
Inhibits inflammatory factors |
|
Salvia miltiorrhiza |
Tanshinones, Salvianolic acids |
Anti-angiogenesis |
Inhibits tumor cell migration |
Inhibits ECM remodeling |
Inhibits angiogenesis |
Enhances immune response |
Regulates tumor metabolism |
Inhibits inflammation |
|
Coptis chinensis |
Berberine, Coptisine |
Anti-proliferation, pro-apoptosis |
Inhibits tumor cell proliferation |
Inhibits ECM synthesis |
Inhibits angiogenesis |
Activates immune cells |
Improves hypoxic environment |
Inhibits inflammation |
|
Dandelion |
Taraxacin, Flavonoids |
Antioxidant, anti-proliferation |
Enhances immune cell activity |
Enhances ECM degradation |
Inhibits angiogenesis |
Enhances immune surveillance |
Regulates tumor metabolism |
Inhibits inflammatory response |
|
Atractylodes |
Atractylodes lactone, Atractylodin |
Anti-inflammatory, immune regulation |
Promotes immune cell proliferation |
Strengthens ECM structure |
Promotes angiogenesis |
Inhibits immune evasion |
Increases metabolic efficiency |
Inhibits chronic inflammation |
|
Shatar |
Allium polyrhizum |
Antioxidant, anti-inflammatory |
Inhibits tumor growth |
Modulates ECM structure |
Inhibits angiogenesis |
Enhances immune cell activity |
Regulates oxidative stress |
Reduces inflammation |
|
Tsagaan ezen |
Rhodiola quadrifida |
Adaptogenic, anti-tumor |
Enhances immune response |
Stabilizes ECM |
Inhibits angiogenesis |
Modulates immune system |
Improves metabolic function |
Reduces oxidative stress |
|
Nogoon Tsagaan tsetseg |
Astragalus membranaceus |
Immunomodulatory, anti-proliferative |
Enhances T cell function |
Enhances ECM integrity |
Inhibits angiogenesis |
Enhances immune surveillance |
Modulates pH and hypoxia |
Reduces inflammation |
|
Zogan tsegi |
Artemisia spp. |
Anti-tumor, anti-inflammatory |
Inhibits tumor cell proliferation |
Alters ECM composition |
Inhibits angiogenesis |
Modulates immune response |
Regulates oxidative environment |
Reduces chronic inflammation |
|
Mongol noyon |
Cynomorium songaricum |
Anti-tumor, immunomodulatory |
Inhibits tumor growth |
Modulates ECM dynamics |
Inhibits angiogenesis |
Enhances immune function |
Improves metabolic resilience |
Reduces inflammation |
Challenges remain in integrating
Mongolian traditional medicine into mainstream oncology, including issues
related to standardization, quality control [21], and cross-cultural
understanding of diagnostic and treatment practices [34]. Efforts to validate
traditional knowledge through rigorous scientific inquiry and collaborative
research partnerships are essential for expanding the evidence base and
enhancing the acceptance of Mongolian medicine in cancer care [35].
4.Conclusion
The
tumor microenvironment represents a complex and dynamic milieu that plays a
pivotal role in cancer progression and therapy resistance. Understanding the
molecular mechanisms underlying TME modulation is crucial for developing
effective therapeutic strategies that target tumor-promoting interactions while
preserving normal tissue function.
Mongolian medicine, with its
rich tradition of herbal remedies and holistic healing practices, offers
promising avenues for TME modulation and cancer treatment. By harnessing the
bioactive compounds and therapeutic principles of Mongolian medicinal plants,
researchers aim to develop innovative therapies that complement existing
treatment modalities and improve patient outcomes.
Moving forward, continued
research efforts are needed to elucidate the specific mechanisms by which
Mongolian medicinal practices influence the TME and to evaluate their efficacy
in clinical settings. Integrating traditional medicine systems with modern oncology
holds great potential for advancing personalized cancer care and addressing the
multifaceted challenges posed by this complex disease.
References
1. Mareel M, Oliveira
MJ, Madani I: Cancer invasion and metastasis: interacting ecosystems. Virchows Archiv 2009, 454:599-622.
2. Mattiuzzi C, Lippi G: Current cancer epidemiology. Journal
of epidemiology and global health 2019, 9(4):217-222.
3. Wallace
TA, Martin DN, Ambs S: Interactions among genes, tumor biology and the
environment in cancer health disparities: examining the evidence on a national
and global scale. Carcinogenesis 2011, 32(8):1107-1121.
4. Miao
L, Huang L: Exploring the tumor microenvironment with nanoparticles. Nanotechnology-Based
Precision Tools for the Detection and Treatment of Cancer 2015:193-226.
5. Damgaci S, Ibrahim‐Hashim A, Enriquez‐Navas PM,
Pilon‐Thomas S, Guvenis A, Gillies RJ: Hypoxia and
acidosis: immune suppressors and therapeutic targets. Immunology 2018, 154(3):354-362.
6. Castillo-Rodríguez
RA, Trejo-Solís C, Cabrera-Cano A, Gómez-Manzo S,
Dávila-Borja VM: Hypoxia as a modulator of inflammation and immune response in
cancer. Cancers 2022, 14(9):2291.
7. Mao
X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S: Crosstalk
between cancer-associated fibroblasts and immune cells in the tumor
microenvironment: new findings and future perspectives. Molecular cancer 2021, 20:1-30.
8. Ping
Q, Yan R, Cheng X, Wang W, Zhong Y, Hou Z, Shi Y, Wang C, Li R: Cancer-associated
fibroblasts: overview, progress, challenges, and directions. Cancer gene
therapy 2021, 28(9):984-999.
9. Goenka
A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP,
Gangadaran P, Ahn BC: Tumor microenvironment
signaling and therapeutics in cancer progression. Cancer Communications 2023, 43(5):525-561.
10. Neophytou
CM, Panagi M, Stylianopoulos T, Papageorgis
P: The role of tumor microenvironment in cancer metastasis: Molecular
mechanisms and therapeutic opportunities. Cancers 2021, 13(9):2053.
11. Lei
X, Lei Y, Li J-K, Du W-X, Li R-G, Yang J, Li J, Li F, Tan H-B: Immune cells
within the tumor microenvironment: Biological functions and roles in cancer
immunotherapy. Cancer letters 2020, 470:126-133.
12. Ge Z,
Ding S: The crosstalk between tumor-associated macrophages (TAMs) and tumor
cells and the corresponding targeted therapy. Frontiers in oncology 2020, 10:590941.
13. Gao
J, Liang Y, Wang L: Shaping polarization of tumor-associated macrophages in
cancer immunotherapy. Frontiers in immunology 2022, 13:888713.
14. Basak
U, Sarkar T, Mukherjee S, Chakraborty S, Dutta A, Dutta S, Nayak D, Kaushik S,
Das T, Sa G: Tumor-associated macrophages: An effective player of the tumor
microenvironment. Frontiers in Immunology 2023, 14:1295257.
15. Seele
BC: Conservation implications of ethnoveterinary knowledge: a Mongolian case
study. Stellenbosch: Stellenbosch University; 2017.
16. Janes
CR, Hilliard C: Inventing tradition: Tibetan medicine in the post-socialist
contexts of China and Mongolia. In: Tibetan Medicine in the Contemporary World.
edn.: Routledge; 2012: 35-61.
17. Batjargal
A, Solek P, Kukula-Koch W, Urjin B, Koch W, Koman D, Dudzinska
E: Gurgem-7 toxicity assessment: Regulation of cell survival or death by
traditional Mongolian prescription. Ecotoxicology and Environmental Safety 2022,
239:113660.
18. Dauletkhan Y, Han TY, Ashim J, Baasanmunkh
S, Khajidsuren A, Yu W, Naidansuren
P, Gulzada U, Choi KD, Oyungerel B: Anti-Melanoma
efficacy of traditional multi-herbal extracts from mongolian
ethnomedicine on B16F10 murine cells. Current Research in Biotechnology 2024, 7:100217.
19. Serrano
A, Ros G, Nieto G: Bioactive compounds and extracts from traditional herbs and
their potential anti-inflammatory health effects. Medicines 2018, 5(3):76.
20. Narenmandula, Hongmei, Ding X, Li K, Hashentuya,
Yang D, Wendurige, Yang R, Yang D, Tana: The
Traditional Mongolian Medicine Qiqirigan-8 Effects on Lipid Metabolism and
Inflammation in Obesity: Pharmacodynamic Evaluation and Relevant Metabolites. Frontiers
in Pharmacology 2022, 13:863532.
21. Kletter
C, GLASL S, THALHAMMER T, NARANTUYA S: Traditional Mongolian medicine–a
potential for drug discovery. Scientia Pharmaceutica 2008, 76(1):49-64.
22. Gerke
B: Tradition and modernity in Mongolian medicine. Journal of Alternative &
Complementary Medicine 2004, 10(5):743-749.
23. Rajabnezhad M, Niknejad S,
Mehrabi Koushki J: Mongolian Traditional Medicine, a
Combination of Other Nations' Traditional Medicine. Medical History 2019, 11(40):19-31.
24. Hicks
A, Hicks J, Mole P: Five element constitutional acupuncture: Elsevier Health
Sciences; 2010.
25. Batchuluun
SS: Iconography of the White Old Man—Tsagaan Ebugen’s
Image in Mongolian Ethnic Art. Известия Уральского федерального университета Серия 2 Гуманитарные науки 2021, 23(4):23-31.
26. Urtnasan
M, Munkhjargal B, Danzanchadav
G, Turuutuvshin A, Zolzaya A, Almaz B, Long C: Folk
nomenclature of plants in Cistanche deserticola-associated community in South Gobi, Mongolia. Plant
Divers 2020, 10.
27. Batbayar
B-E: The Mongols Respond to the Declaration? In: Twentieth Century Mongolia. edn.: Brill; 2000: 157-162.
28. Li
X-T, Zhao J: An approach to the nature of Qi in TCM-Qi and bioenergy. Recent
advances in theories and practice of Chinese Medicine 2012:79-108.
29. Huang
R, Yang K, Zhang Z, Song L, Dong K, Xie X, Hai X: Mongolian HCC vs. Caucasian
HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting
Difference. Biochemical Genetics 2024, 62(3):2279-2295.
30. Liu
Z, Han Z, Xue L, Wei W: The mechanism of Traditional Mongolian medicine Daruqi
particles on inflammation. Gene 2024, 920:148530.
31. King
E, Cobbin DM, Walsh S, Ryan D: The reliable measurement of radial pulse
characteristics. Acupuncture in medicine 2002, 20(4):150-159.
32. Xie
J, Jing C, Zhang Z, Xu J, Duan Y, Xu D: Digital tongue image analyses for
health assessment. Medical Review 2021, 1(2):172-198.
33. Pitschmann A, Purevsuren S, Obmann A, Natsagdorj D, Gunbilig
D, Narantuya S, Kletter C, Glasl S: Traditional Mongolian medicine: history and
status quo. Phytochemistry reviews 2013, 12:943-959.
34. Tugjamba N, Walkerden G, Miller
F: Adaptation strategies of nomadic herders in northeast Mongolia: climate, globalisation and traditional knowledge. Local Environment 2021,
26(4):411-430.
35. Sen
S, Chakraborty R: Revival, modernization and integration of Indian traditional
herbal medicine in clinical practice: Importance, challenges and future. Journal
of traditional and complementary medicine 2017, 7(2):234-244.
Share and Cite
Ren Z. J., Zeng D.R., Wang P. Q., Wang R., Zhou B. Q., Zhang Y. The identification of potential inhibitors of SARS-CoV-2 spike protein by virtual screening FDA-approved compound library. Chronic Diseases Prevention Review 2024, 8 (29), 1. DOI: 10.54762/CDPR2024.29.1-4.
Ren Z. J., Zeng D.R., Wang P. Q., Wang R., Zhou B. Q., Zhang Y. (2024). The identification of potential inhibitors of SARS-CoV-2 spike protein by virtual screening FDA-approved compound library. Chronic Diseases Prevention Review, 8(29), 1. https://doi.org/10.54762/CDPR2024.29.1-4
Chicago/Turabian StyleRen Z. J., Zeng D.R., Wang P. Q., Wang R., Zhou B. Q., Zhang Y. 2024. "The identification of potential inhibitors of SARS-CoV-2 spike protein by virtual screening FDA-approved compound library." Chronic Diseases Prevention Review 8 (29):1. doi: 10.54762/CDPR2024.29.1-4.
